Tags

Type your tag names separated by a space and hit enter

Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency.
Neuroimage 2011; 54(2):1307-14N

Abstract

The glutamatergic N-methyl-D-aspartate (NMDA) receptor has been implicated in the pathophysiology of schizophrenia. Administered to healthy volunteers, a subanesthetic dose of the non-competitive NMDA receptor antagonist ketamine leads to psychopathological symptoms similar to those observed in schizophrenia. In patients with schizophrenia, ketamine exacerbates the core symptoms of illness, supporting the hypothesis of a glutamatergic dysfunction. In a counterbalanced, placebo-controlled, double-blind study design, healthy subjects were administered a continuous subanesthetic S-ketamine infusion while differences in BOLD responses measured with fMRI were detected. During the scanning period, subjects performed continuous overt verbal fluency tasks (phonological, lexical and semantic). Ketamine-induced psychopathological symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). Ketamine elicited psychosis like psychopathology. Post-hoc t-tests revealed significant differences between placebo and ketamine for the amounts of words generated during lexical and semantic verbal fluency, while the phonological domain remained unaffected. Ketamine led to enhanced cortical activations in supramarginal and frontal brain regions for phonological and lexical verbal fluency, but not for semantic verbal fluency. Ketamine induces activation changes in healthy subjects similar to those observed in patients with schizophrenia, particularly in frontal and temporal brain regions. Our results provide further support for the hypothesis of an NMDA receptor dysfunction in the pathophysiology of schizophrenia.

Authors+Show Affiliations

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany. nagels@med.uni-marburg.deNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20727411

Citation

Nagels, Arne, et al. "Neural Correlates of S-ketamine Induced Psychosis During Overt Continuous Verbal Fluency." NeuroImage, vol. 54, no. 2, 2011, pp. 1307-14.
Nagels A, Kirner-Veselinovic A, Krach S, et al. Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency. Neuroimage. 2011;54(2):1307-14.
Nagels, A., Kirner-Veselinovic, A., Krach, S., & Kircher, T. (2011). Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency. NeuroImage, 54(2), pp. 1307-14. doi:10.1016/j.neuroimage.2010.08.021.
Nagels A, et al. Neural Correlates of S-ketamine Induced Psychosis During Overt Continuous Verbal Fluency. Neuroimage. 2011 Jan 15;54(2):1307-14. PubMed PMID: 20727411.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency. AU - Nagels,Arne, AU - Kirner-Veselinovic,André, AU - Krach,Sören, AU - Kircher,Tilo, Y1 - 2010/08/18/ PY - 2010/07/14/received PY - 2010/08/09/revised PY - 2010/08/10/accepted PY - 2010/8/24/entrez PY - 2010/8/24/pubmed PY - 2011/4/6/medline SP - 1307 EP - 14 JF - NeuroImage JO - Neuroimage VL - 54 IS - 2 N2 - The glutamatergic N-methyl-D-aspartate (NMDA) receptor has been implicated in the pathophysiology of schizophrenia. Administered to healthy volunteers, a subanesthetic dose of the non-competitive NMDA receptor antagonist ketamine leads to psychopathological symptoms similar to those observed in schizophrenia. In patients with schizophrenia, ketamine exacerbates the core symptoms of illness, supporting the hypothesis of a glutamatergic dysfunction. In a counterbalanced, placebo-controlled, double-blind study design, healthy subjects were administered a continuous subanesthetic S-ketamine infusion while differences in BOLD responses measured with fMRI were detected. During the scanning period, subjects performed continuous overt verbal fluency tasks (phonological, lexical and semantic). Ketamine-induced psychopathological symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). Ketamine elicited psychosis like psychopathology. Post-hoc t-tests revealed significant differences between placebo and ketamine for the amounts of words generated during lexical and semantic verbal fluency, while the phonological domain remained unaffected. Ketamine led to enhanced cortical activations in supramarginal and frontal brain regions for phonological and lexical verbal fluency, but not for semantic verbal fluency. Ketamine induces activation changes in healthy subjects similar to those observed in patients with schizophrenia, particularly in frontal and temporal brain regions. Our results provide further support for the hypothesis of an NMDA receptor dysfunction in the pathophysiology of schizophrenia. SN - 1095-9572 UR - https://www.unboundmedicine.com/medline/citation/20727411/Neural_correlates_of_S_ketamine_induced_psychosis_during_overt_continuous_verbal_fluency_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1053-8119(10)01103-1 DB - PRIME DP - Unbound Medicine ER -